Press release content from PR Newswire. The AP news staff was not involved in its creation.
Health at Scale Forms External Advisory Board
May 6, 2021 GMT
Health at Scale Corporation logo (PRNewsfoto/Health at Scale Corporation)
SAN JOSE, Calif., May 6, 2021 /PRNewswire/ Health at Scale, a health care machine intelligence company, today announced the formation of an external advisory board of health care experts. The board will bring deep clinical, economic, and public policy experience to guide the company in its mission to make health care delivery more personalized and precise. Founding members include Benjamin Scirica, MD, MPH, Guy David, PhD, Lauren Aronson, Mark Fendrick, MD, and Michael Chernew, PhD.
Renowned Harvard Doctors to Star in Groundbreaking Documentary BETTER Aimed at Curbing the Diabesity Epidemic and Ending All Diet Wars
Share Article
A Transformative Food, Diabetes, and Body-Positivity Documentary that Sets Out to Change the Way We Eat, Think, and Live, BETTER Unveils a Revolutionary Way of Eating and Thinking with a Harvard Medical Doctor Backed Approach
BETTER is an award-winning, transformative food, diabetes, and body-positivity documentary that sets out to change the way we eat, think, and live.
“We need a much more sophisticated approach to weight control that will help people succeed over the long term,” stated Dr. David Ludwig, Professor at Harvard Medical School. “If we don’t do something about it, this generation of children will lead shorter, less healthful lives than their parents.”
Share this article
Share this article
ZUG, Switzerland, May 4, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces that it has entered into a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for the protocol titled, A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer (CATIQ P3).
Isoquercetin, the Company s lead product candidate, employs a novel pathway that is based on a new mechanism of action to prevent or reverse thrombus formation with a profile that potentially conveys substantially lowered bleeding risk compared to current standard of care. These mechanisms are related to key thrombotic pathways, including the inhibition of soluble P-selectin, which is known to help prevent or reduce thro
In a blockbuster 1997 film
Wag the Dog, Robert De Niro plays a fixer extraordinaire who’s summoned to the White House after a potential front-page scandal threatens to sink the president’s reelection. To deflect attention away from this controversy, De Niro and Hollywood producer Dustin Hoffman plan a fake war, or pageant, as they call it.
As De Niro famously quipped, “We’re not going to have a war. We’re going to have the
appearance of a war.” Playing on this sentiment, director Barry Levinson stressed, “We’re reaching a point where it’s no longer easy to differentiate between what’s fabricated and what’s real.”
E-Mail
How has the field of nutrition changed how we eat and live? What new discoveries and advances may be just over the horizon? Get the latest insights from leading nutrition scientists and practitioners at NUTRITION 2021 LIVE ONLINE, the flagship online meeting of the American Society for Nutrition.
Complimentary press passes are available for the meeting, to be held virtually June 7-10, 2021. Explore the meeting program for scientific sessions, special events and featured speakers, including the following renowned individuals: Rafael Pérez-Escamilla, PhD, Professor at Yale School of Public Health, has contributed to important improvements in breastfeeding and other maternal, infant and young child nutrition outcomes. His work has also advanced efforts to address household food security and health disparities. Pérez-Escamilla will receive the Kellogg Prize for Lifetime Achievements in International Nutrition. He will deliver remarks on Monday, June 7 from 6-7:30 p.m. Ea